F 
23.52
-0.04%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$1.57bn
FY2019FY2025
Net income
−$34.8m
FY2019FY2025
Free cash flow
$140.9m
FY2019FY2025
Shareholders' equity
$1.31bn
FY2019FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | $1.57bn | $860.2m | $763.8m | $810.0m | $712.3m | $509.2m | $481.8m |
| Research and development | $101.9m | $63.8m | $49.3m | $51.9m | $45.5m | $35.4m | $33.2m |
| Operating income | $141.2m | −$62.4m | $81.5m | $94.3m | $63.8m | −$2.0m | $92.2m |
| Net income | −$34.8m | −$110.3m | $37.3m | $64.6m | $16.1m | −$84.0m | $34.3m |
| Diluted earnings per share | -0.20 | -0.68 | 0.26 | 0.43 | 0.11 | -0.68 | 0.21 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Total assets | $3.83bn | $3.92bn | $1.63bn | $1.89bn | $1.89bn | $1.76bn | $544.7m |
| Cash and short-term investments | $240.0m | $168.7m | $213.8m | $393.6m | $293.6m | $154.1m | $81.9m |
| Total liabilities | $2.52bn | $2.62bn | $723.9m | $759.2m | $754.3m | $969.4m | $639.0m |
| Debt | $2.08bn | $2.14bn | $558.5m | $556.8m | $555.8m | $788.0m | $540.8m |
| Shareholders' equity | $1.31bn | $1.31bn | $906.7m | $1.13bn | $1.13bn | $794.3m | −$94.2m |
| Shares outstanding | 173m | 163m | 145m | 150m | 152m | 123m | 164m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Cash from operations | $195.1m | $28.2m | $162.8m | $212.8m | $148.7m | $52.2m | $71.6m |
| Capital spending | −$54.3m | −$1.7m | −$27.7m | −$28.5m | −$23.8m | −$17.7m | −$16.7m |
| Free cash flow | $140.9m | $26.5m | $135.1m | $184.2m | $124.9m | $34.5m | $54.9m |
| Dividends paid | −$133,000 | −$255,000 | −$217.7m | — | −$313,000 | −$23.8m | −$23.8m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $448.8m | $385.2m | $420.0m | $409.2m | $390.6m | $354.6m | $307.1m | $199.1m |
| Operating income | $57.0m | $34.1m | $46.2m | $42.2m | $37.7m | $7.6m | −$80.7m | $9.1m |
| Net income | $16.9m | $2.2m | $3.5m | $2.6m | $308,000 | −$41.2m | −$100.4m | −$8.9m |
| Diluted earnings per share | 0.10 | 0.01 | 0.02 | 0.01 | 0.00 | -0.24 | -0.62 | -0.05 |
| Cash from operations | $73.0m | $49.0m | $65.0m | $72.0m | $37.0m | $19.0m | −$85.0m | $43.0m |
| Capital spending | −$4.0m | −$2.0m | — | −$13.0m | −$9.0m | — | −$10.0m | −$12.0m |
| Free cash flow | $69.0m | $47.0m | — | $59.0m | $28.0m | — | −$95.0m | $31.0m |
| Total assets | $3.75bn | $3.75bn | $3.83bn | $3.86bn | $3.87bn | $3.87bn | $3.92bn | $1.66bn |
| Cash and short-term investments | $237.9m | $225.9m | $240.0m | $216.8m | $184.3m | $172.0m | $168.7m | $307.4m |
| Debt | $2.04bn | $2.06bn | $2.08bn | $2.11bn | $2.13bn | $2.14bn | $2.15bn | $562.4m |
| Shareholders' equity | $1.29bn | $1.29bn | $1.31bn | $1.30bn | $1.30bn | $1.28bn | $1.31bn | $920.7m |
Financial ratios
Data as of 1 Nov 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Operating margin | 8.3% | -7.3% | 10.7% | 11.6% | 7.3% | -0.4% |
| Net margin | -2.2% | -12.8% | 4.9% | 8.0% | 2.3% | -16.5% |
| Return on equity | -2.7% | -8.4% | 4.1% | 5.7% | 1.4% | -10.6% |
| Return on assets | -0.9% | -2.8% | 2.3% | 3.4% | 0.9% | -4.8% |
| Free cash flow yield | 6.7% | 0.9% | 6.1% | 7.4% | 5.2% | 2.6% |
| Revenue growth | 83.0% | 12.6% | -5.7% | 13.7% | 39.9% | 5.7% |
| Earnings growth | -68.4% | -395.7% | -42.3% | 302.5% | -119.1% | -345.3% |
| Current ratio | 2.44x | 1.90x | 4.39x | 5.62x | 4.26x | 2.84x |
| Debt to equity | 1.59x | 1.64x | 0.62x | 0.50x | 0.49x | 0.99x |
| Equity ratio | 34.3% | 33.3% | 55.6% | 59.7% | 60.0% | 45.0% |
| Interest coverage | 0.78x | -1.21x | 2.47x | 10.25x | 2.08x | -0.04x |
| R&D as a share of sales | 6.5% | 7.4% | 6.5% | 6.4% | 6.4% | 7.0% |
| Buybacks as a share of market value | -6.4% | -12.3% | 3.4% | 1.5% | -23.5% | 24.8% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 24.8% | 25.3% | 9.4% |
| Operating income | 14.4% | — | 3.7% |
| Net income | — | -16.2% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | 3.2% | 6.4% | 6.0% | 9.8% |
| Net margin | -6.0% | -1.1% | -2.1% | 2.5% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Price to earnings | -72.3 | -27.6 | 64.4 | 30.2 | 180.6 |
| Price to sales | 1.6 | 3.5 | 3.1 | 2.4 | 4.1 |
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Return | -21% | 18% | 27% | -24% | -15% |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years. Last went ex-dividend on 18 Aug 2023.
| FY2023 | |
|---|---|
| Paid in the year | 1.50 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.